FDA Drug Recalls

Recalls / Brands / Dobutamine

Dobutamine

2 FDA drug recalls involving brand “Dobutamine” — 1 Class I.

DateClassProductFirm
2025-05-28Class IIDOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Pfizer Inc.
2014-01-10Class IDOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for HospiraHospira Inc.